Edelman, a global communications and marketing company, has named Alan Maine as its new senior director, it was reported yesterday.
Maine has earlier served as head of policy and public affairs at Pfizer UK, where he was responsible for government affairs and market access policy development activity, covering both corporate and therapy area public affairs. During his time at Pfizer, Maine also worked with industry associations on campaigns, policies and initiatives relating to access to medicines. Prior to his time with Pfizer, Maine was head of government affairs at Wyeth Pharmaceuticals, later acquired by Pfizer, and has held other roles with Merck Sharpe & Dohme.
Kate Hawker, managing director for Edelman UK, said, 'We are very excited about Alan joining Edelman as he brings with him such great knowledge and insight of the complex challenges in the UK.'
Zydus enters exclusive talks to acquire majority stake in Amplitude Surgical
Adcendo's ADCE-T02 Phase I study IND application receives US FDA approval
WHO grants Actinogen Medical's Xanamem/UE2343 non-proprietary name 'emestedastat'
IVFMD physicians named 2025 Castle Connolly Top Doctors
HOPE Therapeutics and NRx Pharmaceuticals select BTIG as financial advisor
Partillion Bioscience opens pre-orders for Nanovial Multicell Assay Antibody Discovery Kits
Champions Oncology expands bioanalytical services with new technology
Petauri's Nicole Lodowski named to MM+M's 40 Under 40 for 2025
WuXi XDC Cayman wins 'Best CDMO' at World ADC Awards 2024
Nektar Therapeutics agrees sale of Huntsville manufacturing facility and reagent supply business